Our goal was to noninvasively measure chemotherapy-induced changes in the expression of critical tumor growth genes. To achieve this goal, we used radionuclide and optical methods to measure'/> Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct
首页> 外文期刊>The Journal of Nuclear Medicine >Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct
【24h】

Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct

机译:可视化的端粒酶逆转录酶(hTERT)启动子活性使用三峰融合报告人构建。

获取原文
           

摘要

id="p-1">Our goal was to noninvasively measure chemotherapy-induced changes in the expression of critical tumor growth genes. To achieve this goal, we used radionuclide and optical methods to measure changes in human telomerase reverse transcriptase (hTERT) gene expression in tumor cells before and after 5-fluorouracil treatment. >Methods: A fusion reporter construct, containing humanized Renilla luciferase (hrl, for bioluminescent imaging), monomeric red fluorescence protein 1 (mrfp1, for fluorescent imaging), and a truncated thymidine kinase (ttk, for imaging of radiolabeled acycloguanosines), was placed under the control of hTERT promoter fragments. These constructs were introduced into tumor cell lines with and without hTERT expression. Transfected cells were treated with 5-fluorouracil, a chemotherapeutic that decreases hTERT gene expression, and treatment-induced changes in hTERT promoter activity were imaged. >Results: When the fusion construct is introduced into cell lines that express hTERT, all 3 reporter systems are highly expressed and hTERT promoter activity can be visualized. Cell lines lacking hTERT transcription show no significant reporter expression. Decreases in hTERT gene expression caused by 5-fluorouracil treatment could be visualized in living 293T cells by both fluorescent microscopy and bioluminescent imaging. >Conclusion: hTERT promoter activity can be monitored by 1 radionuclide and 2 optical reporter systems using a single reporter construct. This in vitro study provides evidence that our multimodality reporter construct can be used to study the expression of a critical tumor growth gene in living subjects.
机译:id =“ p-1”>我们的目标是非侵入性地测量化学疗法诱导的关键肿瘤生长基因表达的变化。为了实现此目标,我们使用了放射性核素和光学方法来测量5-氟尿嘧啶治疗前后肿瘤细胞中人类端粒酶逆转录酶(hTERT)基因表达的变化。 >方法:一种融合报告基因构建体,包含人源化的荧光素酶( hrl,用于生物发光成像),单体红色荧光蛋白1( mrfp1 ,用于荧光成像的)和截短的胸苷激酶(用于放射标记的无环鸟苷成像的 ttk,)置于hTERT启动子片段的控制之下。将这些构建体引入具有和不具有hTERT表达的肿瘤细胞系中。用5-氟尿嘧啶(一种降低hTERT基因表达的化学疗法)处理转染的细胞,并对hTERT启动子活性的治疗诱导变化进行成像。 >结果:将融合构建体引入表达hTERT的细胞系中时,所有3个报告基因系统均得到高度表达,并且hTERT启动子活性可以可视化。缺少hTERT转录的细胞系未显示明显的报告基因表达。由5-氟尿嘧啶处理引起的hTERT基因表达的降低可以通过荧光显微镜和生物发光成像在活的293T细胞中观察到。 >结论:hTERT启动子活性可以通过1个放射性核素和2个光学报告子系统使用单个报告子构建体进行监测。这项体外研究提供了证据,表明我们的多模态报道基因构建体可用于研究活体受试者中关键肿瘤生长基因的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号